Vortrag
Phase 1, Randomized, Parallel-Group, Double-Blind, Placebo-Controlled Trial to Evaluate the Effects of Erenumab (AMG 334) and Concomitant Sumatriptan on Blood Pressure in Healthy Subjects
Speaker
Datum:
12.10.2017 ,
Zeit:
13:39
|
Thema: 25. kein Themengebiet